Semen Aesculi Extract is extracted from Aesculus chinensis Bunge, which can suppress the metastasis of triple-negative breast cancer by inhibiting epithelial-mesenchymal transition via down-regulating LOXL2 expression.

Semen astragali complanati Extract is extracted from Semen Astragali Complanati, the dried ripe seed of Flatstem Milkvetch (Astragalus complanatus Bunge) (Leguminosae). The major contents of Semen astragali complanati include fatty acids, amino acids, polysaccharides, flavonoids, triterpene glycosides and trace elements. Semen astragali complanati exhibits a number of therapeutic effects on chronic diseases such as cardiovascular […]

Semen Canavaliae Extract is extracted from Canavalia Gladiate,, which is a natural antioxidant and antibacterial agent with potential health benefits as well as application in the food industry.

Semen Celosiae Extract is extracted from Semen Celosiae.

Semen Ginkgo Extract is extracted from Semen Ginkgo.

Semen Lablab Album Extract is extracted from Baibiandouren (Lablab Semen Album), a white seed from the leguminosae plant Dolichos lablab L. Tuchao Baibiandouren (Lablab Semen Album fried with earth, TCBBDR) exerts therapeutic effects on diabetes through multi-compound and multi-target collaboration.

Semen litchi Extract is extracted from Litchi chinensis, which has an anti-hepatoma effect and inhibits angiogenesis by targeting VEGFR in hepatocellular carcinoma.

Semen Persicae Extract is extracted from Semen Persicae.

Semen Pruni Extract is extracted from Semen pruni, which is used for oedema, dermatophytosis, hypertension, constipation, chronic tracheitis, and other conditions.

Semen Ziziphi Spinosae Extract is extracted from the seeds of Semen Ziziphi Spinosae, which can attenuate blood-brain barrier dysfunction induced by lipopolysaccharide by targeting the FAK-DOCK180-Rac1-WAVE2-Arp3 signaling pathway.

Semiaquilegiae Radix Extract is extracted from the tuberous root of Semiaquilegia adoxoides.

Seminis Juglandis Septum Extract is obtained from Diaphragma juglandis, which is the dry wood diaphragm of walnut kernel, is one of the well-known by-products of walnut production.

Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer’s disease. MW : 150 kD.

Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer’s disease. MW : 150 kD.

Semorinemab (Anti-Tau) is a humanized IgG4 monoclonal antibody that targets the N-terminal domain of tau (amino acid residues 6-23). Semorinemab has the potential to be used in research on Alzheimer’s disease. MW : 150 kD.

Senicapoc (ICA-17043) is a Gardos channel(Ca2+-activated K+ channel; KCa3.1) blocker with an IC50 of 11 nM and produces dose-dependent increases in hemoglobin and decreases in markers of hemolysis. Senicapoc blocks Ca2+-induced rubidium flux from human RBCs with an IC50 value of 11 nM and inhibits RBC dehydration with IC50 of 30 nM.

Senicapoc (ICA-17043) is a Gardos channel(Ca2+-activated K+ channel; KCa3.1) blocker with an IC50 of 11 nM and produces dose-dependent increases in hemoglobin and decreases in markers of hemolysis. Senicapoc blocks Ca2+-induced rubidium flux from human RBCs with an IC50 value of 11 nM and inhibits RBC dehydration with IC50 of 30 nM.

Sennae Folium Extract is extracted from Sennae Folium.

Sephin-1 (NSC-65390) is a selective inhibitor of a holophosphatase, a small molecule that safely and selectively inhibits a regulatory subunit of protein phosphatase 1 in vivo. Sephin-1 (NSC-65390) selectively bounds and inhibits the stress-induced PPP1R15A.

Seralutinib (PK10571, GB002) is a novel PDGFR kinase inhibitor with IC50s of 8 nM and 10 nM for PDGFRα and PDGFRβ in enzyme assays, respectively.

Seralutinib (PK10571, GB002) is a novel PDGFR kinase inhibitor with IC50s of 8 nM and 10 nM for PDGFRα and PDGFRβ in enzyme assays, respectively.

Serclutamab (Anti-ERBB1 / EGFR / HER1) is a monoclonal antibody targeting epidermal growth factor receptor (EGFR). It can be used in research of advanced solid tumors for advanced glioblastoma. MW :150 KD.

Serclutamab (Anti-ERBB1 / EGFR / HER1) is a monoclonal antibody targeting epidermal growth factor receptor (EGFR). It can be used in research of advanced solid tumors for advanced glioblastoma. MW :150 KD.

Serclutamab (Anti-ERBB1 / EGFR / HER1) is a monoclonal antibody targeting epidermal growth factor receptor (EGFR). It can be used in research of advanced solid tumors for advanced glioblastoma. MW :150 KD.

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.

Serclutamab Talirine (ABBV-321), is an antibody-drug conjugate (ADC) composed of an humanized immunoglobulin G1 anti-EGFR monoclonal antibody conjugated to a pyrrolobenzodiazepine (PBD) dimer via a maleimidocaproyl-valine-alanine linker. Serclutamab Talirine has the potential for use in advanced solid tumors associated with overexpression of the epidermal growth factor receptor (EGFR) or its ligands.